Indivior stock gains 2.96 percent on USD 8.13 dividend plan

Published on 09/29/2026 at 10:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Indivior stock traded at USD 36.88 on September 28, 2026, while a conditional USD 8.13 dividend awaits the Supernus merger. Q2 revenue reached USD 343 million.

Moderne Pharma-Produktionsanlage mit Glasfassade und Industrieanlagen im Tageslicht — Indivior PLC mit ISIN GB00BYZ0C031 betreibt moderne Pharma-Produktionsanlage für innovative Suchtmedizin-Präparate weltweit an Patienten, Illustration mit AI erstellt.

Indivior stock (ISIN GB00BYZ0C031) was trading at USD 36.88 on Nasdaq at 4:00 p.m. ET on September 28, 2026, up 2.96 percent from the prior close. The company declared a conditional USD 8.13 special dividend on September 17, 2026, giving the merger timetable a direct value for existing shareholders.

Dividend depends on merger approval

According to Indivior on September 17, 2026, the USD 8.13 payment is reserved for holders of record on October 30, 2026, and depends on completion of the Supernus merger.

The expected merger date is November 2, 2026, with payment scheduled for November 6, 2026 if the transaction closes. The filing also identifies merger approval, regulatory clearance and additional indebtedness used to fund the dividend as material conditions and risks.

Q2 revenue beat consensus

Yahoo Finance reported on September 2, 2026 that Indivior generated USD 343 million of revenue in the second quarter of 2026, up 13.6 percent year over year and above the USD 308 million consensus estimate.

Adjusted EPS reached USD 1.15 versus a USD 0.97 consensus estimate. Sublocade revenue rose 21 percent year over year to USD 253 million, while adjusted EBITDA increased 111 percent to USD 186 million, making product growth and cost control the two operating drivers behind the stronger outlook.

Analyst target stays above price

MarketBeat reported on September 20, 2026 that six analysts rated Indivior Buy and one rated it Hold, producing a Moderate Buy consensus and an average 12-month target of USD 45.17. That target lies 22.48 percent above the Nasdaq price of USD 36.88.

Stock remains below yearly high

Indivior stock stood 13.85 percent below its 52-week high of USD 42.81 on September 28, 2026, while the 52-week low was USD 22.56. Market capitalization was USD 4.6 billion and trading volume was 1,159,557 shares on the same session.